Skip to content
VuFind
Book Bag:
0
items
(Full)
Institutional Login
Language
English
Deutsch
All Fields
Title
Author
Subject
ISBN/ISSN
K10+-PPN
OCLC Number
Find
Advanced
Start
Monitoring CDK4/6 inhibitor re...
Cite this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Export to RDF
Export to BibTeX
Export to RIS
Save to List
Permanent link
Monitoring CDK4/6 inhibitor resistance in metastatic breast cancer patients using liquid biopsy markers
Saved in:
Bibliographic Details
Main Author:
Becker, Lisa Maria
(Author)
Format:
Book/Monograph
Thesis
Language:
English
Published:
Heidelberg
[2020?]
Subjects:
Hochschulschrift
Online Access:
Author Notes:
presented by Lisa Maria Becker (Dipl.-Biochem.) ; referees: Prof. Dr. Andreas Trumpp, Dr. Richard Harbottle
Description
Staff View
Description
Description not available.
Similar Items
CDK4/6 inhibitors in the treatment of metastatic breast cancer
by: Ettl, Johannes, et al.
Published: (2017)
Clinical use of liquid biopsy in metastatic breast cancer: an ESSO-EYSAC international survey
by: Suppan, Ina, et al.
Published: (2025)
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer
by: Michel, Laura L., et al.
Published: (2025)
Liquid biopsy: value for melanoma therapy?
by: Buder-Bakhaya, Kristina, et al.
Published: (2017)
CDK4/CDK6 inhibitors synergize with Midostaurin, Avapritinib, and Nintedanib in inducing growth inhibition in KIT D816V+ neoplastic mast cells
by: Schneeweiss-Gleixner, Mathias, et al.
Published: (2022)